View in EDS HTML Full Text PDF Full Text

Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.

Saved in:
Bibliographic Details
Title: Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.
Authors: Ye Z; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China., Rae CL; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, United Kingdom., Nombela C; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Ham T; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Rittman T; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Jones PS; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Rodríguez PV; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Coyle-Gilchrist I; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Regenthal R; Division of Clinical Pharmacology, Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany., Altena E; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Housden CR; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Maxwell H; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Sahakian BJ; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom., Barker RA; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Robbins TW; Department of Psychology, University of Cambridge, Cambridge, United Kingdom.; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom., Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, United Kingdom.; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom.
Source: Human brain mapping [Hum Brain Mapp] 2016 Mar; Vol. 37 (3), pp. 1026-37. Date of Electronic Publication: 2016 Jan 12.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 9419065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0193 (Electronic) Linking ISSN: 10659471 NLM ISO Abbreviation: Hum Brain Mapp Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26757216
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ye+Z%22">Ye Z</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Rae+CL%22">Rae CL</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Nombela+C%22">Nombela C</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ham+T%22">Ham T</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rittman+T%22">Rittman T</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jones+PS%22">Jones PS</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rodríguez+PV%22">Rodríguez PV</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Coyle-Gilchrist+I%22">Coyle-Gilchrist I</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Regenthal+R%22">Regenthal R</searchLink>; Division of Clinical Pharmacology, Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Altena+E%22">Altena E</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Housden+CR%22">Housden CR</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Maxwell+H%22">Maxwell H</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sahakian+BJ%22">Sahakian BJ</searchLink>; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barker+RA%22">Barker RA</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Robbins+TW%22">Robbins TW</searchLink>; Department of Psychology, University of Cambridge, Cambridge, United Kingdom.; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rowe+JB%22">Rowe JB</searchLink>; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.; Medical Research Council Cognition and Brain Sciences Unit, Cambridge, United Kingdom.; Behavioural and Clinical Neuroscience Institute, Cambridge, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229419065%22">Human brain mapping</searchLink> [Hum Brain Mapp] 2016 Mar; Vol. 37 (3), pp. 1026-37. <i>Date of Electronic Publication: </i>2016 Jan 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9419065 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0193 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210659471%22">10659471 </searchLink><i>NLM ISO Abbreviation: </i>Hum Brain Mapp <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26757216
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hbm.23087
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1026
    Titles:
      – TitleFull: Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ye Z
      – PersonEntity:
          Name:
            NameFull: Rae CL
      – PersonEntity:
          Name:
            NameFull: Nombela C
      – PersonEntity:
          Name:
            NameFull: Ham T
      – PersonEntity:
          Name:
            NameFull: Rittman T
      – PersonEntity:
          Name:
            NameFull: Jones PS
      – PersonEntity:
          Name:
            NameFull: Rodríguez PV
      – PersonEntity:
          Name:
            NameFull: Coyle-Gilchrist I
      – PersonEntity:
          Name:
            NameFull: Regenthal R
      – PersonEntity:
          Name:
            NameFull: Altena E
      – PersonEntity:
          Name:
            NameFull: Housden CR
      – PersonEntity:
          Name:
            NameFull: Maxwell H
      – PersonEntity:
          Name:
            NameFull: Sahakian BJ
      – PersonEntity:
          Name:
            NameFull: Barker RA
      – PersonEntity:
          Name:
            NameFull: Robbins TW
      – PersonEntity:
          Name:
            NameFull: Rowe JB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2016 Mar
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0193
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Human brain mapping
              Type: main
ResultId 1